You are here

XPhyto Therapeutics Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
XPHY
CSE Index: 
Currency: 

XPhyto is a science-based cannabis company focused on formulation, clinical validation, and emerging European markets. XPhyto’s 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH, has been granted a unique German cannabis cultivation and extraction licence for scientific purposes by the German Federal Institute for Drugs and Medical Devices (BfArM). XPhyto is pursuing additional opportunities in Germany including cultivation, processing, manufacturing, import, and distribution. In Canada, two exclusive 5-year engagements with the Faculty of Pharmacy at a major Canadian university provide certified extraction, isolation, and formulation facilities, drug research and development expertise, as well as commercial analytical testing capability.

You are here

XPhyto Therapeutics Corp. (XPHY)

SEDAR Information

Company Info

Address
Suite 270 - 1820 Fir Street
Vancouver, BC V7Y 1G5
Canada
Phone
780-818-6422
Email
info@xphyto.com
Listing date
Wednesday, July 31, 2019
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
47,107,705
Reserved for Issuance: 
24,041,105

Bulletins

30/07/2019

2019-0724 – New Listing - XPhyto Therapeutics Corp. (XPHY)

le 30 juillet/July 2019

The common shares of XPhyto Therapeutics Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

09_16_Cannabis_Global_Capital_Commercialization_Conference_Website

Cannabis Global Capital & Commercialization

Monday, September 16, 2019 -
8:30am to 2:00pm
09_21_RAISE_on_the_WEST_COAST_Conference_Website

RAISE on the WEST COAST Conference

Saturday, September 21, 2019 -
8:00am to 5:30pm